Minimize Uncertainty – Make Informed Decisions – Succeed

Cardiovascular

Cardiovascular Today—December 10, 2025

December 11, 2025BioPharma and Tech News,TirzepatideTAVI,Cardiovascular News,Hotwire,AltaValve,Valvosoft,Triceps,Tenecteplase,Ketamine,Etomidate,SSi Mantra,stroke rehabilitation,heart valve treatment

This week’s cardiovascular update brings together new clinical evidence, device…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: EpilepsyGTx $33m Series A

December 11, 2025clinical trials,AAV,gene therapy,Regulatory,biopharma,epilepsy,NICE,Neuromodulation,Lucid Diligence Brief,MHRA,payer accessdiligence

Lucid Diligence Brief: EpilepsyGTx $33m Series A Professional audiences only.…

by Timos Papagatsias

Immunology

Immunology Today—December 10, 2025

December 10, 2025Autoimmune dry eye disease,CONMED,cancer,Abeona,gene therapy,Medical Care Technologies,abbvie,Navigator Medicines,novartis,OSE Immunotherapeutics,BioPharma and Tech News,Iolyx Therapeutics,autoimmune diseases,Laboratoires Théa,melanoma,Orna Therapeutics,ZEVASKYN,Fate Therapeutics,Lupus,Gastroenterology exit strategy,hidradenitis suppurativa,Minimally invasive surgery,Immunology News,Surgical portfolio,Recessive dystrophic epidermolysis bullosa,Bispecific antibody therapySkin wounds,Chronic inflammation

This week’s Immunology update highlights key advances in gene therapy,…

by LucidQuest

Women's_Health

Women’s Health Video Recap—December 10, 2025

December 10, 2025HIV infection,migraine,multiple sclerosis,Alzheimer's Disease,BioPharma and Tech News,DEMENTIA,endometriosis,cervical cancer,Bristol Myers Squibb,Women's Health News,BioNxt Solutions,American Cancer Society,Johnson and JohnsonKallyope,CervoMed

This biweekly Women’s Health video roundup brings together new clinical…

by LucidQuest

Neuroscience

Neuroscience Video Recap—December 10, 2025

December 10, 2025Kallyope,Nipocalimab,migraine,Cobenfy,Alzheimer's Disease,Elismetrep,abbvie,Bexicaserin,BioPharma and Tech News,Lynk Pharmaceuticals,Parkinson's Disease,GEN Pharmaceuticals,Eli Lilly,Childhood onset epilepsies,Bristol Myers Squibb,Alzheimer’s psychosis,Lundbeck,Neuroscience News,generalized myasthenia gravis,neuroinflammatory diseases,AtogepantJohnson and Johnson,Indiana University

This biweekly Neuroscience video recap highlights major regulatory wins,…

by LucidQuest

Neuroscience

Neuroscience Today — December 10, 2025

December 10, 2025Praxis Precision Medicines,PBS Australia,migraine,Nipocalimab,Alzheimer's Disease,Cobenfy,BioPharma and Tech News,Elismetrep,Eli Lilly,Bexicaserin,epilepsy,Relutrigine,Bimekizumab,Toripalimab,Ocrelizumab,Pegcetacoplan,Bristol Myers Squibb,Lundbeck,Neuroscience News,generalized myasthenia gravis,Johnson and JohnsonIndiana University,Kallyope

This week’s Neuroscience update features major regulatory decisions, strong…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: SanegeneBio RNAi $110 million Series B

December 10, 2025clinical trials,nephrology,Regulatory,biopharma,hypertension,Lucid Diligence Brief,payer access,venture financing,partnerships,RNAicomplement pathway

Lucid Diligence Brief: SanegeneBio RNAi $110 million Series B Professional…

by Timos Papagatsias

ESMO Immuno-Oncology 2025 Preview: Key Highlights to Watch

December 9, 2025PD-L1 combined positive score,Neoantigen prediction,Our Insights,ESMO Immuno-Oncology Congress 2025,digital pathology,immuno-oncology,Biomarkers,Conference Previews,ai in oncology,Checkpoint inhibitors,PD-1 combinations,Perioperative immunotherapy,B-cell architecture analysis,BRCA mutation status,Mismatch repair deficiencyTumor-infiltrating lymphocyte therapy,Radiotherapy synergy

ESMO Immuno-Oncology 2025 at a glance Get ready for ESMO Immuno-Oncology…

by LucidQuest

Obesity Weekly News

Obesity Video Recap—December 9, 2025

December 9, 2025Gan and Lee,CagriSema,FDA,MFDS,semaglutide,Amylin therapy,BioPharma and Tech News,GLP-1,Novo Nordisk,Mounjaro,Tirzepatide,Eli Lilly,WHO,type 2 diabetes,Innovent Biologics,Hanmi PharmaceuticalNMPA,Obesity News

This biweekly obesity video recap covers major GLP-1 therapeutic advances,…

by LucidQuest

Obesity Weekly News

Obesity Today—December 9, 2025

December 9, 2025wegovy,semaglutide,BioPharma and Tech News,obesity,Novo Nordisk,Mounjaro,Tirzepatide,Eli Lilly,type 2 diabetes,GLP-1 receptor agonistObesity News,CagriSema

This week’s obesity update spotlights key developments, regulatory milestones,…

by LucidQuest

Endocrinology

Endocrinology Today—December 9, 2025

December 9, 2025BioPharma and Tech News,Mounjarothyroid cancer,type 2 diabetes,Acromegaly,Endocrinology News,Polycystic ovary syndrome,Continuous Glucose Monitoring,Medtronic MiniMed 780G,FreeStyle Libre 3,PRISM system

Catch the latest endocrinology news, featuring industry updates, clinical…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics

December 9, 2025clinical trials,market access,Regulatory,rare disease,biopharma,Lucid Diligence Brief,payer access,diligence,M&A,Liver diseasehepatitis D

Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics Professional…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.